Greg and Robert explode some of the persistent myths around genetic testing and dive in to the future of genetic testing amongst healthy populations
News & Media
Use our Project or Categories filter to narrow down your news search.
What would happen if everyone got their genome sequenced? This question is no longer the stuff of science fiction. Instead, it is a research question that Senior Genetic Counselor Carrie Blout and her colleagues at the Genomes2People initiative at Brigham and Women’s hospital are trying to answer. We discuss the medical, psychological, and economic impact … Continued
Harry Glorikian guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women’s Hospital and the Broad Institute of Harvard and MIT. They dig into the individual genome, how genomic data is being used, and the impact … Continued
Mike Richman of VA Research Communications interviews Dr. Jason Vassy, a clinician and researcher at the VA Boston Healthcare System. Vassy is leading a study that is focusing on whether a test for a specific gene can help patients and doctors choose the right type and dose of statin drugs, which are often used by … Continued
Growing up in a small town in Illinois, musician Pete Wentz didn’t look or feel like others in his community, and never really felt that he fit in. So, he set out to create an identity of his own. On the latest episode of Spit, host Baratunde Thurston sits with Pete and medical geneticist and … Continued
The third and final interview conducted with Dr. Robert Green about specific circumstances that could arise from genetic sequencing starting from infancy.
“The promises and peril that could come from reading your full genome.” Dr. Robert Green discusses some very important questions about what information you could find in your genome.
Robert C. Green sits down with Rob Reid to discuss the advantages and disadvantages of looking into your own genome.
Much of genetic mutation classification is still to be determined by researchers, but what they do know can potentially help many patients with hypertrophic cardiomyopathy in this specific study.